trustmebro.to/r/…
✓ checked
trust me, bro:
here is the receipt.
the claim

Pyrimethamine and sulfadiazine treatment eliminates Toxoplasma gondii tissue cysts

the verdict
REFUTED
the evidence says no
Recorded sources
0 sources for · 2 against

Counts group repeated records of the same source within each side. They do not measure evidence strength or source independence.

Is it true that Pyrimethamine and sulfadiazine treatment eliminates Toxoplasma gondii tissue cysts?

No. Standard treatments like pyrimethamine and sulfadiazine are effective against the acute tachyzoite stage of Toxoplasma gondii but fail to eliminate the latent tissue cysts characteristic of chronic infection.

Verdict: REFUTED · 0 sources for, 2 against · Last checked

The analysis

The claim states that pyrimethamine and sulfadiazine treatment eliminates Toxoplasma gondii tissue cysts. Multiple retrieved sources explicitly state that current clinical drugs, including pyrimethamine and sulfadiazine, are ineffective during the chronic phase and cannot eliminate or eradicate brain tissue cysts, rendering the claim refuted.

Evidence against · 2
Efficacy of Guanabenz Combination Therapy against Chronic Toxoplasmosis across Multiple Mouse Strains.
2020
States that the tissue cyst reservoir of Toxoplasma gondii is currently refractory to clinically available therapeutics and cannot be completely eliminated.
Get citation
J, M., JS, D., & Jr, S. W. (2020). Efficacy of Guanabenz Combination Therapy against Chronic Toxoplasmosis across Multiple Mouse Strains.. doi.org. https://doi.org/10.1128/aac.00539-20

See more details
More against · 1
Blue light-emitting diode phototherapy reduces cerebral parasitic load and inflammation in murine congenital toxoplasmosis model.
2026
Notes that current standard drugs including pyrimethamine and sulfadiazine lack efficacy in the chronic phase and fail to eradicate the parasite.
Get citation
Toledo, D., Carlos, N., Dantas-Vieira, G. C., Burle, M. M. d. C., Duarte-Junior, L. d. A., Castro, M. L. C., Santos, T. R. d., Costa, G. P., Azevedo, C. S. d., Costa, D. C., Rabelo, É. M., Bianchi, R. F., Martins-Duarte, É. S., & Talvani, A. (2026). Blue light-emitting diode phototherapy reduces cerebral parasitic load and inflammation in murine congenital toxoplasmosis model.. doi.org. https://doi.org/10.1016/j.imbio.2026.153182

What does the evidence say?

The claim states that pyrimethamine and sulfadiazine treatment eliminates Toxoplasma gondii tissue cysts. Multiple retrieved sources explicitly state that current clinical drugs, including pyrimethamine and sulfadiazine, are ineffective during the chronic phase and cannot eliminate or eradicate brain tissue cysts, rendering the claim refuted.

Receipt History
first checked06 Aug 2026
judged → REFUTED · 1706 Aug 2026
Anyone with this link can read the claim and its public receipt, including any personal information in that text. Open permanent receipt.
Check your own claim
Challenge the receipt
Requests are recorded for review. This does not start an automatic check or guarantee a response time.

See the evidence timeline

Citation formatting by citeproc-js (Frank Bennett) and the Citation Style Language project. Source and licenses.

This receipt is an automated verdict against our published method · not an opinion about any author or publication.
Terms · Privacy · How verdicts work